Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 2500.00 | 1881.33 | 1698.00 | 3582.00 | 0.4740 | -0.1045 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 3513.00 | 3582.00 | 0.9807 | 0.9586 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 2500.00 | 1881.33 | 3424.00 | 3582.00 | 0.9559 | 0.9052 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 3701.00 | 3582.00 | 1.0332 | 1.0716 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 2167.00 | 3582.00 | 0.6050 | 0.1644 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 1813.00 | 3582.00 | 0.5061 | -0.0390 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 3915.00 | 3582.00 | 1.0930 | 1.2008 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3602.00 | 3582.00 | 1.0056 | 1.0120 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 3721.00 | 3582.00 | 1.0388 | 1.0837 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 2500.00 | 1881.33 | 3765.00 | 3582.00 | 1.0511 | 1.1102 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3375.00 | 3582.00 | 0.9422 | 0.8759 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 2500.00 | 1881.33 | 3305.00 | 3582.00 | 0.9227 | 0.8340 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3095.00 | 3582.00 | 0.8640 | 0.7089 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 3785.00 | 3582.00 | 1.0567 | 1.1223 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 2500.00 | 1881.33 | 1740.00 | 3582.00 | 0.4858 | -0.0806 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3792.00 | 3582.00 | 1.0586 | 1.1265 | |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 2215.00 | 3582.00 | 0.6184 | 0.1921 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 2826.00 | 3582.00 | 0.7889 | 0.5496 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3759.00 | 3582.00 | 1.0494 | 1.1066 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 7.00 | 3582.00 | 0.0020 | -0.9976 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 2.00 | 5493.00 | 0.0004 | -0.9814 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5443.00 | 5493.00 | 0.9909 | 0.9892 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 3154.00 | 5493.00 | 0.5742 | 0.4410 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5592.00 | 5493.00 | 1.0180 | 1.0212 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 4639.00 | 5493.00 | 0.8445 | 0.8100 |